Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Association of Intracranial Atherosclerotic Disease With Incident Dementia
abstract
This abstract is available on the publisher's site.
Access this abstract nowBACKGROUND
Studies of the neurovascular contribution to dementia have largely focused on cerebral small vessel disease (CSVD), but the role of intracranial atherosclerotic disease (ICAD) remains unknown in the general population. The objective of this study was to determine the risk of incident dementia from ICAD after adjusting for CSVD and cardiovascular risk factors in a US community-based cohort.
METHODS
We acquired brain magnetic resonance imaging examinations from 2011 through 2013 in 1980 Black and White participants in the ARIC study (Atherosclerosis Risk in Communities), a prospective cohort conducted in 4 US communities. Magnetic resonance imaging examinations included high-resolution vessel wall magnetic resonance imaging and magnetic resonance angiography to identify ICAD. Of these participants, 1590 without dementia, without missing covariates, and with adequate magnetic resonance imaging image quality were followed through 2019 for incident dementia. Associations between ICAD and incident dementia were assessed using Cox proportional hazard ratios adjusted for CSVD (characterized by white matter hyperintensities, lacunar infarctions, and microhemorrhages), APOE4 genotype, and cardiovascular risk factors.
RESULTS
The mean age (SD) of study participants was 77.4 (5.2) years. ICAD was detected in 34.6% of participants. After a median follow-up of 5.6 years, 286 participants developed dementia. Compared with participants without ICAD, the fully adjusted hazard ratios (95% CIs) for incident dementia in participants with any ICAD, with ICAD only causing stenosis ≤50%, and with ICAD causing stenosis >50% in ≥1 vessel were 1.57 (1.17-2.11), 1.41 (1.02-1.95), and 1.94 (1.32-2.84), respectively. ICAD was associated with dementia even among participants with low white matter hyperintensities burden, a marker of CSVD.
CONCLUSIONS
ICAD was associated with an increased risk of incident dementia, independent of CSVD, APOE4 genotype, and cardiovascular risk factors. The increased risk of dementia was evident even among participants with low CSVD burden, a group less likely to be affected by vascular dementia, and in participants with ICAD causing only low-grade stenosis. Our results suggest that ICAD may partially mediate the effect that cardiovascular risk factors have on the brain leading to dementia. Both ICAD and CSVD must be considered to understand the vascular contributions to cognitive decline.
Additional Info
Disclosure statements are available on the authors' profiles:
Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities)
Circulation 2024 Aug 01;[EPub Ahead of Print], D Zhao, E Guallar, Y Qiao, DS Knopman, M Palatino, RF Gottesman, TH Mosley, BA WassermanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intracranial atherosclerotic disease and dementia
Often, when we think of dementia, we think of Alzheimer's dementia with all the amyloid plaques and tangles that cause neurons to die off. However, anything that causes neurons to die can lead to dementia. And here we often think of stroke and how it destroys brain tissue, leading to disability and dementia.
Usually, we think of the extracranial vessels. We think of carotid stenosis and clot formation from carotid plaque causing strokes. However, what about the vessels that are inside the cranium? If there is ongoing atherosclerosis within these vessels, the blood flow would be compromised, which could lead to damaged neurons. This is referred to as intracranial atherosclerotic disease (ICAD). This disease differs from small vessel disease, called cerebral small vessel disease (CSVD). CSVD causes those white matter lesions that we see on MRI scans.
For this study, the researchers wanted to know whether narrowing of the intracranial arteries would increase dementia risk. This would be the segment of arteries between the large external arteries and the small cerebral vessels.
The ARIC Study (Atherosclerosis Risk in Communities) had MRI scans of 1590 people who did not have dementia. The authors noticed that 34.6% of the patients had ICAD as seen on the MRI scans. After 5.6 years of follow-up, 286 patients developed dementia.
When the authors examined patients with ICAD with greater than 50% stenosis, the risk of dementia was 94% higher (HR, 1.94; 95% CI, 1.32–2.84) compared with those without ICAD. For patients with any level of ICAD compared with those with no ICAD, the risk of dementia was 57% higher (1.57; 95% CI, 1.17–2.11). These results were after adjusting for cardiovascular risk factors, APOE4, and CSVD. This means that atherosclerosis in the intracranial vessels independently drives dementia risk.
This makes sense because if blood flow to neurons is not enough, these neurons cannot maintain homeostasis. Hence, they become damaged and may eventually die. Therefore, to prevent dementia, we need to keep the blood vessels happy.
So, whatever is good for the heart is also good for the brain. Having optimum blood pressure, cholesterol, and sugar levels, avoiding smoking, and reducing inflammation in blood vessels all reduce vascular damage. Even vaccinations that prevent infections like influenza, RSV infection, and COVID-19, could reduce inflammation and protect the vasculature. In addition, we should avoid PM2.5 pollution particles and microplastics, which have been linked to vascular damage.
So, let us be good to our hearts and brains, and hopefully, we can “forget” about dementia.